Double-Drug attack on aggressive breast cancer before surgery
Disease control
Not yet recruiting
This study tests whether combining two drugs (SKB264 and pembrolizumab) given before surgery can eliminate cancer cells in patients with stage II-III triple-negative breast cancer. The trial will enroll 52 patients who haven't had previous cancer treatment to see if this combinat…
Phase: PHASE2 • Sponsor: Yantai Yuhuangding Hospital • Aim: Disease control
Last updated Mar 18, 2026 14:41 UTC